ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 30 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $258 | – | 46 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2019 | $3,000 | +200.0% | 500 | +13.6% | 0.00% | – |
| Q4 2018 | $1,000 | -75.0% | 440 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | 0.0% | 440 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | -42.9% | 440 | -25.4% | 0.00% | – |
| Q1 2018 | $7,000 | 0.0% | 590 | 0.0% | 0.00% | – |
| Q4 2017 | $7,000 | +16.7% | 590 | -14.5% | 0.00% | – |
| Q3 2017 | $6,000 | -68.4% | 690 | -37.6% | 0.00% | -100.0% |
| Q2 2017 | $19,000 | +72.7% | 1,105 | +104.6% | 0.00% | – |
| Q1 2017 | $11,000 | -82.0% | 540 | -86.2% | 0.00% | -100.0% |
| Q4 2016 | $61,000 | +144.0% | 3,900 | +105.3% | 0.00% | +200.0% |
| Q3 2016 | $25,000 | +525.0% | 1,900 | +216.7% | 0.00% | – |
| Q2 2016 | $4,000 | +33.3% | 600 | +20.0% | 0.00% | – |
| Q1 2016 | $3,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cruiser Capital Advisors, LLC | 36,888 | $301,000 | 0.15% |
| Kazazian Asset Management, LLC | 18,792 | $153,000 | 0.14% |
| Fiduciary Trust Co International of Pennsylvania | 202,100 | $1,649,000 | 0.07% |
| Engineers Gate Manager LP | 66,270 | $541,000 | 0.04% |
| THOMPSON DAVIS & CO., INC. | 1,534 | $13,000 | 0.03% |
| ZEKE CAPITAL ADVISORS, LLC | 23,700 | $193,000 | 0.02% |
| A.R.T. Advisors, LLC | 43,360 | $353,000 | 0.02% |
| Cutler Group LLC / CA | 20,822 | $186,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 63,614 | $519,000,000 | 0.01% |
| FNY Investment Advisers, LLC | 6,000 | $48,000 | 0.01% |